Hemangioma surgery: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 19: | Line 19: | ||
*Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries. | *Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries. | ||
*Small remnants of disease are then left for involution. | *Small remnants of disease are then left for involution. | ||
==Phototherapy== | |||
===Pulsed dye laser=== | ===Pulsed dye laser=== | ||
Pulsed dye laser is considered to be effective choice for a series of skin disorders including superficial hemangiomas.<ref name="CaucanasPaquet2011">{{cite journal|last1=Caucanas|first1=Marie|last2=Paquet|first2=Philippe|last3=Henry|first3=Frédérique|last4=Piérard-Franchimont|first4=Claudine|last5=Reginster|first5=Marie-Annick|last6=Piérard|first6=Gérald E.|title=Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy|journal=Case Reports in Dermatological Medicine|volume=2011|year=2011|pages=1–5|issn=2090-6463|doi=10.1155/2011/253607}}</ref> | Pulsed dye laser is considered to be effective choice for a series of skin disorders including superficial hemangiomas.<ref name="CaucanasPaquet2011">{{cite journal|last1=Caucanas|first1=Marie|last2=Paquet|first2=Philippe|last3=Henry|first3=Frédérique|last4=Piérard-Franchimont|first4=Claudine|last5=Reginster|first5=Marie-Annick|last6=Piérard|first6=Gérald E.|title=Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy|journal=Case Reports in Dermatological Medicine|volume=2011|year=2011|pages=1–5|issn=2090-6463|doi=10.1155/2011/253607}}</ref> | ||
*Residual erythema and telangiectasias frequently remain in involuted hemangiomas and are best treated by selective photothermolysis using the flash pulse dye laser (FPDL). | *Residual erythema and telangiectasias frequently remain in involuted hemangiomas and are best treated by selective photothermolysis using the flash pulse dye laser (FPDL). | ||
*Ulcerative lesions during proliferation can be treated with FPDL to induce healing and new epidermal growth. | *Ulcerative lesions during proliferation can be treated with FPDL to induce healing and new epidermal growth. | ||
===Intense pulsed light=== | |||
*IPL flash lamps emit broadband polychromatic high-intensity light in the wavelength spectrum ranging 515-1200nm.<ref name="CaucanasPaquet2011">{{cite journal|last1=Caucanas|first1=Marie|last2=Paquet|first2=Philippe|last3=Henry|first3=Frédérique|last4=Piérard-Franchimont|first4=Claudine|last5=Reginster|first5=Marie-Annick|last6=Piérard|first6=Gérald E.|title=Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy|journal=Case Reports in Dermatological Medicine|volume=2011|year=2011|pages=1–5|issn=2090-6463|doi=10.1155/2011/253607}}</ref> | |||
*They target vessels at various depths inside the skin. | |||
*The effect relies on selective photothermolysis. | |||
*The indication spectrum includes vascular tumors including hemangiomas. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 21:13, 20 November 2015
|
Hemangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemangioma surgery On the Web |
|
American Roentgen Ray Society Images of Hemangioma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Surgery is not the first-line treatment option for patients with hemangioma. It is usually reserved for patients with either massive protuberant proliferating hemangioma and lesions that are refractory to less invasive treatments.[1][2]
Surgery
- Surgical management involves excision, laser treatment or both.
- Intralesional steroid treatment is also an option for focal hemangiomas such as:
- Parotid
- Nasal tip
- Subglottis
- Eyelid
- Repeat therapy is often required, but systemic side effects are limited.
- Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas.
- Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries.
- Small remnants of disease are then left for involution.
Excision
- Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas.
- Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries.
- Small remnants of disease are then left for involution.
Phototherapy
Pulsed dye laser
Pulsed dye laser is considered to be effective choice for a series of skin disorders including superficial hemangiomas.[3]
- Residual erythema and telangiectasias frequently remain in involuted hemangiomas and are best treated by selective photothermolysis using the flash pulse dye laser (FPDL).
- Ulcerative lesions during proliferation can be treated with FPDL to induce healing and new epidermal growth.
Intense pulsed light
- IPL flash lamps emit broadband polychromatic high-intensity light in the wavelength spectrum ranging 515-1200nm.[3]
- They target vessels at various depths inside the skin.
- The effect relies on selective photothermolysis.
- The indication spectrum includes vascular tumors including hemangiomas.
References
- ↑ Callahan, Alison B.; Yoon, Michael K. (2012). "Infantile hemangiomas: A review". Saudi Journal of Ophthalmology. 26 (3): 283–291. doi:10.1016/j.sjopt.2012.05.004. ISSN 1319-4534.
- ↑ Richter, Gresham T.; Friedman, Adva B. (2012). "Hemangiomas and Vascular Malformations: Current Theory and Management". International Journal of Pediatrics. 2012: 1–10. doi:10.1155/2012/645678. ISSN 1687-9740.
- ↑ 3.0 3.1 Caucanas, Marie; Paquet, Philippe; Henry, Frédérique; Piérard-Franchimont, Claudine; Reginster, Marie-Annick; Piérard, Gérald E. (2011). "Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy". Case Reports in Dermatological Medicine. 2011: 1–5. doi:10.1155/2011/253607. ISSN 2090-6463.